Cargando…

Daratumumab as a Frontline Immunosuppression for Pure Red Cell Aplasia after Major ABO-mismatched Allogeneic Hematopoietic Stem Cell Transplantation

Detalles Bibliográficos
Autores principales:	Asawapanumas, Thiti, Chanswangphuwana, Chantiya, Watanaboonyongcharoen, Phandee, Rojnuckarin, Ponlapat, Bunworasate, Udomsak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059067/ https://www.ncbi.nlm.nih.gov/pubmed/35509968 http://dx.doi.org/10.1016/j.lrr.2022.100314

Ejemplares similares

Prognostic factors and impact of CMV reactivation on acute myeloid leukemia patients after HLA-matched myeloablative allogeneic stem cell transplantation in a high CMV prevalence country
por: Chanswangphuwana, Chantiya, et al.
Publicado: (2023)

Cold agglutinin disease following SARS‐CoV‐2 and Mycoplasma pneumoniae co‐infections
por: Moonla, Chatphatai, et al.
Publicado: (2020)

Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation
por: Martino, Rodrigo, et al.
Publicado: (2021)

P1189: ENDOTHELIAL ACTIVATION AND STRESS INDEX IS AN INDEPENDENT PROGNOSTIC FACTOR OF DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH STANDARD IMMUNOCHEMOTHERAPY
por: Thanhakun, Ronakrit, et al.
Publicado: (2023)

Case report: Successful treatment with daratumumab for pure red cell aplasia in a patient with mixed lymphoid chimerism after ABO-mismatched stem cell transplant for sickle cell disease
por: Dovern, E., et al.
Publicado: (2023)

Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia
por: Gangat, Naseema, et al.
Publicado: (2022)

Prevalence of thrombocytopenia, anti–platelet factor 4 antibodies and D‐dimer elevation in Thai people After ChAdOx1 nCoV‐19 vaccination
por: Uaprasert, Noppacharn, et al.
Publicado: (2021)

Safety of the second dose of the ChAdOx1 nCoV‐19 vaccine in people with persistent anti–platelet factor 4 antibodies
por: Uaprasert, Noppacharn, et al.
Publicado: (2021)

The reliability of FEbrile Neutropenia after ChEmotherapy (FENCE) scores in predicting granulocyte colony-stimulating factor breakthrough febrile neutropenia among patients with lymphoma undergoing first-cycle chemotherapy: A prospective observational study
por: Thungthong, Pravinwan, et al.
Publicado: (2023)

Successful Treatment of Pure Red Cell Aplasia with Rituximab in Patients after ABO-Compatible Allogeneic Hematopoietic Stem Cell Transplantation
por: Jung, Sung-Hoon, et al.
Publicado: (2012)

Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation
por: Handisurya, Ammon, et al.
Publicado: (2020)

Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation
por: Zhu, Panpan, et al.
Publicado: (2022)

Myelodysplastic Syndrome with Erythroid Aplasia following Pure Red Cell Aplasia
por: Kim, Hyoung Doo, et al.
Publicado: (2004)

Clinical characteristics of oral chronic graft-versus-host disease according to the 2014 National Institutes of Health (USA) consensus criteria
por: Pengpis, Nawaporn, et al.
Publicado: (2023)

Nonhealing Ulcers with Rimming of the Adipose Tissues
por: Wantavornprasert, Kittipong, et al.
Publicado: (2022)

Pure Red Cell Aplasia with Del(20q) Sensitive for Immunosuppressive Treatment
por: Vo, Anh Khoi, et al.
Publicado: (2020)

ABO Mismatch in Allogeneic Hematopoietic Stem Cell Transplant: Effect on Short- and Long-term Outcomes
por: Valentini, Caterina Giovanna, et al.
Publicado: (2021)

Pure red cell aplasia and associated thymoma
por: Rosu, Cristian, et al.
Publicado: (2011)

Lenalidomide-Induced Pure Red Cell Aplasia
por: Dolai, Tuphan Kanti, et al.
Publicado: (2014)

Pure White Cell Aplasia and Necrotizing Myositis
por: Kim, Peter Geon, et al.
Publicado: (2016)

Emtricitabine-induced pure red cell aplasia
por: Manickchund, Nithendra, et al.
Publicado: (2019)

Erythropoietin‐induced pure red cell aplasia
por: Yeung, Vivian K. P.
Publicado: (2022)

Pure Red Cell Aplasia Associated With Thymoma
por: Thangatorai, Ramesh
Publicado: (2023)

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation
por: Ibrahim, Uroosa, et al.
Publicado: (2023)

TKI-induced pure red cell aplasia: first case report of pure red cell aplasia with both imatinib and nilotinib
por: Poudyal, Bishesh Sharma, et al.
Publicado: (2016)

Direct Oral Anticoagulants and Travel-related Venous Thromboembolism
por: Chamnanchanunt, Supat, et al.
Publicado: (2018)

P1238: GERMLINE HAVCR2 MUTATIONS AND THEIR RELATION TO THE CLINICAL SPECTRUM OF SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA AND HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: RESULTS FROM A MULTICENTER STUDY
por: Polprasert, Chantana, et al.
Publicado: (2023)

Detection of Red Blood Cell Membrane Proteins in Myelodysplastic Syndromes Using Eosin-5-Maleimide (EMA) Staining by Flow Cytometry
por: Uman, Navavee, et al.
Publicado: (2022)

Pure Red Blood Cell Aplasia and Isoniazid Use
por: Loulergue, Pierre, et al.
Publicado: (2007)

Zidovudine-induced reversible pure red cell aplasia
por: Balakrishnan, Anuja, et al.
Publicado: (2010)

Thymoma associated with hypogammaglobulinaemia and pure red cell aplasia
por: Briones, Juan, et al.
Publicado: (2013)

Rational management approach to pure red cell aplasia
por: Balasubramanian, Suresh Kumar, et al.
Publicado: (2018)

Pure red cell aplasia induced by epoetin zeta
por: Panichi, Vincenzo, et al.
Publicado: (2016)

Pure Red Cell Aplasia Associated with Good Syndrome
por: Okui, Masayuki, et al.
Publicado: (2017)

Isoniazid Induced Pure Red Blood Cell Aplasia
por: Azhar, Waqas, et al.
Publicado: (2020)

Acquired Pure Red Cell Aplasia and Recombinant Erythropoietin
por: Padhi, Somanath, et al.
Publicado: (2021)

Clonal hematopoiesis in adult pure red cell aplasia
por: Fujishima, Naohito, et al.
Publicado: (2021)

Acquired pure red cell aplasia: updated review of treatment
por: Sawada, Kenichi, et al.
Publicado: (2008)

Pure Red Cell Aplasia and Lymphoproliferative Disorders: An Infrequent Association
por: Vlachaki, Efthymia, et al.
Publicado: (2012)

Pure Red Cell Aplasia Caused by Acute Hepatitis A
por: Lee, Tae Heon, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_7tr1jmniru87m279kc8ped4us2